Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Biddeford, ME 04005Phone+1 207-294-5800
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995
- University of Calgary Faculty of MedicineClass of 1988
Certifications & Licensure
- NJ State Medical License 1973 - Present
- IA State Medical License 2023 - 2025
- ME State Medical License 2016 - 2025
- NH State Medical License 2017 - 2025
- NC State Medical License 1993 - 2021
- NY State Medical License 2014 - 2016
- WA State Medical License 1993 - 2015
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Tesetaxel as First-line Therapy for Metastatic Breast Cancer Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPhase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancerHelen K. Chew, Lee S. Schwartzberg, Suprith Badarinath, Peter Rubin, Grace Shumaker
Springerplus. 2014-02-22 - 69 citationsUsing the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani
Journal of Surgical Oncology. 2017-06-01 - 5 citationsPatients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast CancerNoel T. Brewer, Jessica T. DeFrank, Wing Keung Chiu, Joseph G. Ibrahim, Christine M. Walko
Public Health Genomics. 2014-01-01
Press Mentions
- Number of Cancer Clinical Trials to Triple in Maine as NCROP Infuses $5.1M into Maine Health Cancer Care Network (MNCCN)October 7th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: